Monument Therapeutics, a neuroscience company applying digital biomarkers to psychiatric drug development, has secured £850,000 in further funding led by ACF Investors, with participation from Wren Capital, o2h Ventures, and angel investors. The investment will be used to fund its schizophrenia programme and drive the next stage of growth for the company.

Sparta, a provider of real-time intelligence for commodity traders, has secured $42 million in Series B funding led by One Peak, with continued backing from Singular and FirstMark. This investment fuels Sparta’s expansion beyond oil and gas, accelerating its vision to evolve from a data provider into a full-scale AI-powered trading platform – an industry-wide operating system that empowers traders with actionable intelligence and collaborative decision-making.

Cambridge Innovation Capital (CIC), the venture capital firm embedded in the Cambridge ecosystem, has launched a new £100 million Opportunity Fund – anchored by Aviva Investors and British Patient Capital – to invest in growth stage deeptech and life sciences companies.

Magdrive, the startup creating the next-generation of spacecraft propulsion, has announced its $10.5 million seed funding round led by pan-European VC Redalpine.

METYCLE, a digital platform for international secondary metal trade, has successfully closed its €14.1 million Series A funding round. The round was led by 2150 with strong continuous investment from existing investors DFF Ventures, Market One Capital, Partech, and Project A.

Drip Water, the UK’s premier lifestyle water brand founded by British TV chef and musician Big Zuu, announces a strategic equity investment from Raya Holding. The £4 million investment will support the brand’s expansion across the Middle East, bringing its valuation to £100 million.